Bambusa Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -2.30%
- Market cap
- —
- no share count on file
- Filings
- 30
—
—
——
—
——
—
——
—
——
—
——
—
—Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
No financial figures on file for BBTX yet.
Biological products, except diagnostic substances
176 covered companies are filed under this code. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
AMGNAmgen Inc$36.8B10.0%21.0%$252.7BGILDGilead Sciences, Inc.$29.4B2.4%28.9%$208.3BBIIBBiogen Inc.$9.9B2.2%13.1%$37.0BNBIXNeurocrine Biosciences Inc$2.9B21.4%16.7%$17.1BEXELExelixis, Inc.$2.3B7.0%33.7%$17.0BQGENQiagen N.V.$2.1B5.7%20.3%$10.9BMRNAModerna, Inc.$1.9B39.9%145.2%$93.6BHALOHalozyme Therapeutics, Inc.$1.4B37.6%22.7%$11.5B
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, largest by revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Bambusa Therapeutics, Inc. · CIK 2044950 · Engraved from SEC EDGAR